Matches in Wikidata for { <http://www.wikidata.org/entity/Q100760410> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q100760410 description "2020 ވަނަ އަހަރުގެ އޮކްޓޯބަރުމަހުގެ 21ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ލިޔުމެއް" @default.
- Q100760410 description "article scientifique publié en 2020" @default.
- Q100760410 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100760410 description "scientific article published on 21 October 2020" @default.
- Q100760410 description "wetenschappelijk artikel" @default.
- Q100760410 description "наукова стаття, опублікована 21 жовтня 2020" @default.
- Q100760410 name "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 name "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 name "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 type Item @default.
- Q100760410 label "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 label "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 label "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 prefLabel "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 prefLabel "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 prefLabel "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 P1433 Q100760410-1D5FD536-6B06-48E0-92F4-443771113C10 @default.
- Q100760410 P1476 Q100760410-D6FAD5F8-E59C-42C8-8219-268F73130ED4 @default.
- Q100760410 P2093 Q100760410-0249ED27-33C4-403E-9892-E64A38E982BA @default.
- Q100760410 P2093 Q100760410-164AD44D-6DFF-4260-97B9-437E468B33BE @default.
- Q100760410 P2093 Q100760410-1B32B427-5FEC-448E-B58D-23B9E6AC61B8 @default.
- Q100760410 P2093 Q100760410-31A0E79F-34DC-4682-9DC5-F0B244F0BAA4 @default.
- Q100760410 P2093 Q100760410-3F5E10D8-27B7-4CE1-880C-AB6DAD8EB2B4 @default.
- Q100760410 P2093 Q100760410-5D98A0A4-1DAD-4D80-8E32-C21591B78294 @default.
- Q100760410 P2093 Q100760410-62D94658-34A6-43E5-8E86-8A5A3C540C9C @default.
- Q100760410 P2093 Q100760410-76F56AD6-DA17-41EC-8D40-8E7BF0FF4E78 @default.
- Q100760410 P2093 Q100760410-89A305F1-FC72-4576-8D93-A69C6D4755FD @default.
- Q100760410 P2093 Q100760410-B319E5CB-01F1-48ED-B052-C6209E8829A2 @default.
- Q100760410 P2093 Q100760410-D202DAC2-BE62-417E-8D77-B2B65792AFD1 @default.
- Q100760410 P2093 Q100760410-E1A46DA7-CC69-4FF2-B3B0-D4A88226FEC4 @default.
- Q100760410 P2093 Q100760410-ED4C4441-472C-45A3-88D0-DB78DDA6DD8B @default.
- Q100760410 P2093 Q100760410-F4DDEA67-F253-46A2-B5AA-13412A21F03B @default.
- Q100760410 P2093 Q100760410-FF8597DA-E057-468C-B620-3430EC718D33 @default.
- Q100760410 P304 Q100760410-FE4645F6-4E49-4A82-8E8C-779254FD6867 @default.
- Q100760410 P31 Q100760410-3687A9D1-93C4-49B3-9C9A-B5F639F625FC @default.
- Q100760410 P356 Q100760410-5AD1810D-B226-4481-B549-64395B47D690 @default.
- Q100760410 P433 Q100760410-A94B8A96-A74E-4539-9B8A-86DB00394894 @default.
- Q100760410 P478 Q100760410-B4F9494F-1025-49B2-82AF-74D5682874DB @default.
- Q100760410 P50 Q100760410-16F5A81F-5B7E-407F-8ADF-3922B3736080 @default.
- Q100760410 P577 Q100760410-ED11BB25-677D-4845-839C-62BAA41EA8DB @default.
- Q100760410 P698 Q100760410-DE8682C9-A5D1-444A-93E4-F540FFBF100D @default.
- Q100760410 P932 Q100760410-D9691DE3-AB50-48BB-89F0-E67A25A2A938 @default.
- Q100760410 P356 S12885-020-07508-7 @default.
- Q100760410 P698 33087090 @default.
- Q100760410 P1433 Q326300 @default.
- Q100760410 P1476 "The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies" @default.
- Q100760410 P2093 "Chan-Keng Yang" @default.
- Q100760410 P2093 "Chao-Wei Hsu" @default.
- Q100760410 P2093 "Cheng-Tao Lin" @default.
- Q100760410 P2093 "Chi-Yuan Cheng" @default.
- Q100760410 P2093 "Chih-Liang Wang" @default.
- Q100760410 P2093 "Ching-Fu Chang" @default.
- Q100760410 P2093 "Chun-Bing Chen" @default.
- Q100760410 P2093 "Gigin Lin" @default.
- Q100760410 P2093 "I-Wen Chen" @default.
- Q100760410 P2093 "John Wen-Cheng Chang" @default.
- Q100760410 P2093 "Kun-Yun Yeh" @default.
- Q100760410 P2093 "Meng-Ting Peng" @default.
- Q100760410 P2093 "Pei-Wei Huang" @default.
- Q100760410 P2093 "Shir-Hwa Ueng" @default.
- Q100760410 P2093 "Yu-Fen Lin" @default.
- Q100760410 P304 "1018" @default.
- Q100760410 P31 Q13442814 @default.
- Q100760410 P356 "10.1186/S12885-020-07508-7" @default.
- Q100760410 P433 "1" @default.
- Q100760410 P478 "20" @default.
- Q100760410 P50 Q90706184 @default.
- Q100760410 P577 "2020-10-21T00:00:00Z" @default.
- Q100760410 P698 "33087090" @default.
- Q100760410 P932 "7579996" @default.